A PILOT CLINICAL TRIAL TO MONITOR RESPONSE TO CHEMOTHERAPY USING THE CA-62 MARKER OF EPITHELIAL CARCINOMAS

A PILOT CLINICAL TRIAL TO MONITOR RESPONSE TO CHEMOTHERAPY USING THE CA-62 MARKER OF EPITHELIAL CARCINOMAS

The objective of the study was to assess the feasibility of using CA -62 marker of epithelial carcinomas for monitoring treatment response and detecting cancer progression or recurrence during chemotherapy.Material and Methods. A 12-month double-blind clinical trial was conducted by two independent...

Full description

Saved in:

Bibliographic Details
Main Authors:	G. G. Khakimova, Zh. R. Cherkasova, S. A. Tsurkan, G. A. Fedchikov, N. V. Suganov, V. A. Gorbunova
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2019-11-01
Series:	Сибирский онкологический журнал
Subjects:	chemotherapy gastric cancer small-cell lung cancer colorectal cancer neuroendocrine cancer ovarian cancer са-62 cancer antigen immunochemiluminescent assay cancer marker monitoring stable disease disease progression
Online Access:	https://www.siboncoj.ru/jour/article/view/1184
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen
by: Zh. R. Cherkasova, et al.
Published: (2023-03-01)

Exploring NUP62’s role in cancer progression, tumor immunity, and treatment response: insights from multi-omics analysis
by: Lihong Chen, et al.
Published: (2025-03-01)

WDR62 affects the progression of ovarian cancer by regulating the cell cycle
by: Yuqi Yang, et al.
Published: (2025-05-01)

Neuroendocrine cancer of maxillary sinus: case report and literature review
by: T. I. Deshkina, et al.
Published: (2022-02-01)

The Role of CA‐125 in the Management of Ovarian Cancer: A Systematic Review
by: Zohre Momenimovahed, et al.
Published: (2025-03-01)

The inflammatory markers combined with CA125 may predict postoperative survival in endometrial cancer
by: Hongxing Lin, et al.
Published: (2024-12-01)

CS-6-induced p62 accumulation exacerbates DNA damage in colorectal cancer
by: Yitong Gong, et al.
Published: (2025-05-01)

Serum tumour marker (CEA, CA 19-9 and CA 27-29) levels and their association with clinicopathological parameters in Nigerian breast cancer patients
by: Ganiyu Olatunbosun Arinola, et al.
Published: (2025-01-01)

A case of de novo neuroendocrine prostate cancer presented with elevated level of serum CEA carrying BRCA2 mutation: case report and literature review
by: Weizhe Han, et al.
Published: (2025-01-01)

CHROMOGRANIN-A IN THE DIAGNOSIS OF PROSTATE CANCER
by: A. V. Sivkov, et al.
Published: (2015-04-01)

Xenogeneic Testicular Cell Vaccination Induces Long-Term Anti-Cancer Immunity in Mice
by: Victor I. Seledtsov, et al.
Published: (2025-06-01)

Disparities of tumour markers in intraperitoneal drainage fluid between laparoscopic and open radical gastrectomy for gastric cancer
by: Jian Guo, et al.
Published: (2024-05-01)

Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors
by: Rebecca R. J. Collins, et al.
Published: (2025-07-01)

Diagnostic significance of the novel biomarker combination for early-stage non-small cell lung cancer detection: results of the blind clinical study
by: Janneta Tcherkassova, et al.
Published: (2025-05-01)

Metformin in the treatment of colorectal cancer and neuroendocrine tumours
by: Karolina Daniłowska, et al.
Published: (2024-08-01)

Epigenetic abnormalities and neuroendocrine differentiation in prostate cancer
by: G. A. Kovchenko, et al.
Published: (2025-03-01)

Complex clinical and cytological diagnosis of eye adnexa epithelial tumors
by: S. V. Saakyan, et al.
Published: (2024-07-01)

Global burden of cancer in women, 1990–2021: a systematic analysis from the GBD 2021 study
by: Yun Mao, et al.
Published: (2025-08-01)

RESPONSE OF MONONUCLEAR CELLS TO CANCER-ASSOCIATED ANTIGENS, HUMORAL FACTORS OF IMMUNITY, AND PATHOHISTOLOGICAL FINDINGS IN WOMEN WITH GENITAL MALIGNANCIES CERVICAL EPITHELIAL DYSPLASIA
by: A. I. Autenshlus, et al.
Published: (2014-07-01)

Relationship between the transcriptional activity of СT-genes and survival in colorectal cancer patients
by: D. S. Kutilin, et al.
Published: (2022-03-01)

The role of chemoradiotherapy in the treatment of neuroendocrine rectal cancer: case reports
by: S. S. Gordeev, et al.
Published: (2022-09-01)

Everything you ever wanted to know about cancer stem cells in neuroendocrine neoplasms but were afraid to ask
by: Ignacio Ruz-Caracuel, et al.
Published: (2024-12-01)

Molecular classifications of gastric cancer and their clinical potential
by: M. V. Nemtsova, et al.
Published: (2024-06-01)

The Burden and Trends of Gynecological Cancers in Asia from 1980 to 2021, with Projections to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021
by: Yang Yang, et al.
Published: (2025-05-01)

MALIGNANT OVARIAN TUMORS DIAGNOSTICS DIFFICULTIES
by: S. O. Nikoghosyan, et al.
Published: (2018-08-01)

Early detection of digestive system cancers: Insights from enzymatic and non-enzymatic tumour markers
by: Almohanna Thualfeqar, et al.
Published: (2025-01-01)

Advances in the study of the relationship between Porphyromonas gingivalis and various diseases
by: Qinghua Zou, et al.
Published: (2025-08-01)

Promotive effect of cancer-testis antigen CT57 on proliferation, invasion, migration and epithelial-mesenchymal transition of liver cancer cells
by: LUO Lange, et al.
Published: (2024-11-01)

Introduction and expression of PIK3CA E545K in a papillary thyroid cancer BRAF V600E cell line leads to a dedifferentiated aggressive phenotype
by: Nicole Pinto, et al.
Published: (2022-02-01)

Cancer‐testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis
by: Lina Lin, et al.
Published: (2021-12-01)

Risk of colorectal cancer in Parkinson’s disease: a systematic review and meta-analysis of 11 million participants
by: Navid Bidgoli, et al.
Published: (2025-05-01)

CANCER TESTIS ANTIGENS IN CANCER IMMUNOTHERAPY
by: D. I. Vodolazhsky, et al.
Published: (2017-06-01)

Outcomes of Surgical Treatment of Multiple Primary Colorectal and Prostate Cancer
by: I. S. Ignatov, et al.
Published: (2025-02-01)

Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate Cancer
by: Zoe R. Maylin, et al.
Published: (2024-12-01)

Editorial: Current status and recent advances in preclinical models for rare cancers
by: Ewa Krawczyk, et al.
Published: (2025-08-01)

MICROSATELLITE-UNSTABLE COLORECTAL CANCER IN ELDERLY PATIENTS: CLINICAL FEATURES AND THE ROLE OF IMMUNODEFICIENCY
by: D. V. Pashkov, et al.
Published: (2020-03-01)

Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity
by: Jillian S. Weissenrieder, et al.
Published: (2025-05-01)

Case of patient with extramammary Paget’s disease
by: A. Z. Tsitskarava, et al.
Published: (2021-04-01)

Rare Form of Breast Cancer and Lung Foci: Do We Always Have to Wait for Metastases?
by: Е. V. Meskikh, et al.
Published: (2022-10-01)

The Cancer Burden in Sarawak, Malaysia: Sarawak Cancer Report
by: Shirley Siang Ning Tan, et al.
Published: (2025-03-01)